Bumetanide Injection — FDA Drug Shortage

Resolved — Mullan Pharmaceutical Inc.

The FDA lists a drug shortage record for Bumetanide Injection (injection) from Mullan Pharmaceutical Inc. with status Resolved. The shortage was first posted on Dec 13, 2017.

Shortage details

Status
Resolved
Company
Mullan Pharmaceutical Inc.
Package NDC
83301-0080-2
Dosage Form
Injection
Presentation
Bumetanide, Injection, 1 mg/4 mL (0.25 mg/mL) (NDC 83301-0080-2)
Initial Posting
Dec 13, 2017

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.